OrbiMed Capital GP VII LLC's Net Worth
$0
Who is OrbiMed Capital GP VII LLC?
OrbiMed Capital GP VII LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., Fusion Pharmaceuticals Inc., Repare Therapeutics Inc., Arcutis Biotherapeutics, Inc., Theseus Pharmaceuticals, Inc., Kinnate Biopharma Inc., Sierra Oncology, Inc., Synthorx, Inc., Terns Pharmaceuticals, Inc., Galecto, Inc., Passage BIO, Inc., Enliven Therapeutics, Inc., Janux Therapeutics, Inc., Third Harmonic Bio, Inc., Pandion Therapeutics Holdco LLC, and Homology Medicines, Inc..
SEC CIK
OrbiMed Capital GP VII LLC's CIK is 0001760648
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.70% | -250.00K |
$44.01 | -$11,002,500.00 | 1.02M |
Aug 13
| |||
Form 4
| +170.39% | 1.27M |
$16.00 | $6,003,200.00 | 2.01M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fusion Pharmaceuticals Inc. (FUSN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.12M |
$17.00 | $3,265,700.00 | 3.12M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.12% | -8.08K |
$33.97 | -$274,793.91 | 6.55M |
Scheduled
|
Sep 3 - Sep 7
| ||
Form 4
| -0.38% | -37.86K |
$34.05 | -$1,290,550.08 | 9.89M |
Scheduled
|
Aug 31 - Sep 2
| ||
Form 4
| -0.18% | -18.07K |
$34.13 | -$615,747.82 | 9.98M |
Scheduled
|
Aug 26 - Aug 30
| ||
Form 4
| -0.18% | -18.21K |
$34.16 | -$622,426.25 | 10.03M |
Scheduled
|
Aug 23 - Aug 25
| ||
Form 4
| -0.30% | -20.33K |
$34.06 | -$693,210.46 | 6.71M |
Scheduled
|
Aug 17 - Aug 18
| ||
Form 4
|
∞
| 3.38M |
$20.00 | $1,984,000.00 | 3.38M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.97% | -341.97K |
$21.31 | -$7,287,402.01 | 3.95M |
Jun 24
| |||
Form 4
| -6.06% | -878.20K |
$20.69 | -$18,163,608.12 | 13.62M |
Apr 6 - Apr 8
| |||
Form 4
| +10.61% | 496K |
$25.00 | $12,400,000.00 | 5.17M |
Oct 2
| |||
Form 4
| +836.28% | 4.67M |
$17.00 | $9,501,096.00 | 5.23M |
Feb 3 - Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.71M |
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +2.78% | 479.93K |
$3.05 | $1,463,792.60 | 17.71M |
Jul 17
| |||
Form 4
| +1.16% | 192K |
$5.21 | $1,000,320.00 | 16.73M |
Nov 7
| |||
Form 4
| +0.97% | 158.42K |
$9.97 | $1,578,717.49 | 16.54M |
Jan 19 - Jan 21
| |||
Form 4
| +0.27% | 44.72K |
$9.90 | $442,750.42 | 16.38M |
Jan 11 - Jan 13
| |||
Form 4
|
∞
| 16.84M |
$16.00 |
—
| 16.84M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||